121 related articles for article (PubMed ID: 6084615)
1. [A monoclonal antibody, specific for Burkitt's lymphoma, is also a blood group Pk antibody].
Fellous M; Wiels J; Cartron JP; Tursz T
Dev Biol Stand; 1984; 57():293-8. PubMed ID: 6084615
[TBL] [Abstract][Full Text] [Related]
2. 38.13: a monoclonal antibody directed against a Burkitt's lymphoma-associated antigen and its use as carrier for toxins.
Wiels J; Balaña A; Tursz T
IARC Sci Publ; 1985; (60):457-64. PubMed ID: 4065950
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibitory effect of galactose analogs on the binding and cytotoxicity of an anti-globotriaosylceramide monoclonal antibody coupled or not coupled to pokeweed antiviral protein.
Junqua S; Wils P; Mishal Z; Le Pecq JB
Eur J Immunol; 1987 Apr; 17(4):459-64. PubMed ID: 2436922
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pk red blood cell specificity.
Fellous M; Cartron JP; Wiels J; Tursz T
Br J Haematol; 1985 Jul; 60(3):559-65. PubMed ID: 2410009
[TBL] [Abstract][Full Text] [Related]
5. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
6. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody.
Nudelman E; Kannagi R; Hakomori S; Parsons M; Lipinski M; Wiels J; Fellous M; Tursz T
Science; 1983 Apr; 220(4596):509-11. PubMed ID: 6836295
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.
Miyamoto D; Ueno T; Takashima S; Ohta K; Miyawaki T; Suzuki T; Suzuki Y
Glycoconj J; 1997 Apr; 14(3):379-88. PubMed ID: 9147061
[TBL] [Abstract][Full Text] [Related]
8. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
Favrot MC; Philip I; Philip T; Portoukalian J; Doré JF; Lenoir GM
J Natl Cancer Inst; 1984 Oct; 73(4):841-7. PubMed ID: 6592381
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody defining a Burkitt's lymphoma-associated antigen detects carbohydrate on neutral glycolipid.
Lipinski M; Nudelman ED; Wiels J; Parsons M
J Immunol; 1982 Nov; 129(5):2301-4. PubMed ID: 6181167
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies.
Brodin NT; Dahmén J; Nilsson B; Messeter L; Mårtensson S; Heldrup J; Sjögren HO; Lundblad A
Int J Cancer; 1988 Aug; 42(2):185-94. PubMed ID: 2456994
[TBL] [Abstract][Full Text] [Related]
12. Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt's lymphoma variants induced by immunoselection.
Junqua S; Larsen AK; Wils P; Mishal Z; Wiels J; Le Pecq JB
Cancer Res; 1989 Dec; 49(23):6480-6. PubMed ID: 2684394
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Szekely L; Pokrovskaja K; Klein G
Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
[TBL] [Abstract][Full Text] [Related]
14. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
15. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
[TBL] [Abstract][Full Text] [Related]
18. Determination of antibody-complement mediated cytotoxicity using ATP release induced by a monoclonal antibody against the Burkitt lymphoma associated globotriaosylceramide antigen.
Wils P; Junqua S; Le Pecq JB
J Immunol Methods; 1986 Mar; 87(2):217-22. PubMed ID: 2419453
[TBL] [Abstract][Full Text] [Related]
19. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
20. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
